Patient Outcomes

Tailoring medication selection with pharmacogenomic testing

April 1, 2024 - In modern healthcare, pharmacogenomic assessments are helping healthcare providers determine medication selection, ensuring tailored treatment plans for everyone’s unique genetic makeup. Pharmacogenomic Testing Drug–gene testing, referred to as pharmacogenomics or pharmacogenetics, investigates how individual genetic makeup influences the body's response to drugs....


More Articles

Understanding HIV drug resistance, implications for treatment strategies

by Alivia Kaylor

For HIV treatment, the emergence of drug resistance poses a significant challenge. Despite remarkable advancements in antiretroviral therapy (ART), the persistence of HIV in the body and its ability to mutate presents a constant threat to...

Mayo Clinic Launches Weight Loss Prescription Program

by Veronica Salib

On January 16, 2024, the Mayo Clinic Diet, a weight loss program developed and approved by the Mayo Clinic, announced the beta launch of the Mayo Clinic Diet Medical Weight Loss Rx Program. The growing...

Understanding Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)

by Veronica Salib

Although most people think of selective serotonin reuptake inhibitors (SSRIs) when discussing antidepressants, serotonin and norepinephrine reuptake inhibitors (SNRIs) also play a critical role in managing major depressive disorder and...

FDA Approves First Therapy for Progressing Desmoid Tumors

by Veronica Salib

On Monday, November 27, 2023, the United States Food and Drug Administration (FDA) approved Ogsiveo (nirogacestat), making it the first FDA-approved treatment for desmoid tumors. The drug is intended...

Are Therapeutic Advancements Impacting the Demand for Surgery?

by Veronica Salib

According to the 2023 Trilliant Health report on trends shaping the health economy, the overall demand for surgical procedures has declined from 2017 to 2021. Despite declining rates of surgical interventions, the national disease burden...

Exploring Business Development Strategies for Pharma Startups

by Alivia Kaylor

Pharmaceutical startups face significant challenges in the ever-evolving healthcare industry. A 2020 Drug Discovery Today article emphasized that these challenges often result from unclear business models, the absence of a go-to-market...

Research Reveals That Forever Chemicals May Be Linked to Weight Gain

by Veronica Salib

Earlier this month, a study published in Obesity identified a link between weight gain and perfluorinated alkylate substances (PFAS), also known as forever chemicals, independent of dietary habits....

Nearly 1 Million Deaths Annually Are Linked to Antimicrobial Resistance

by Veronica Salib

A recent report from the World Animal Protection (WAP) revealed that almost one million human deaths globally are linked to antibiotic resistance each year, primarily driven by antimicrobial use in...

How Mesenchymal Stem Cells May Reduce the Need for Antirejection Drugs

by Veronica Salib

In a recent press release, Cynata Therapeutics, a biotechnology company, announced a partnership with Leiden University Medical Center (LUMC) to explore how mesenchymal stem cells may reduce the need...

Addressing Racial Inequities in US Cancer Clinical Trials

by Alivia Kaylor

In a recent Phesi analysis of 589,295 patients participating in 6,372 United States cancer clinical trials over the last 15 years, researchers found that 42% of the African American population and 48% of the Latin American population in...

FDA Amends EUA For Pfizer-BioNTech’s COVID-19 Vaccine Booster

by Samantha McGrail

FDA recently amended the emergency use authorization for Pfizer and BioNTech’s COVID-19 vaccine booster to include individuals 5– 11 years of age at least five months after completing the...

Bristol Myers Squibb’s Drug Effective in Plaque Psoriasis Patients

by Samantha McGrail

Bristol Myers Squibb recently announced that its severe plaque psoriasis treatment,  deucravacitinib, elicited durable efficacy and a consistent safety profile in adult...

J&J Appoints Thibaut Mongon CEO of New Consumer Health Company

by Samantha McGrail

Johnson & Johnson recently appointed Thibaut Mongon as chief executive officer and Paul Ruh as chief financial officer designate of its future consumer health company.   With over 20...

Janssen Pharmaceuticals Terminates Collaboration in Hepatitis B, HPV

by Samantha McGrail

The Janssen Pharmaceutical Companies of Johnson & Johnson recently terminated its collaboration with Bavarian Nordic, which developed potential vaccines against the hepatitis B virus and human...

FDA Limits Use of Johnson & Johnson COVID-19 Vaccine

by Samantha McGrail

FDA recently limited the authorized use of Johnson & Johnson's COVID-19 vaccine to include individuals 18 years of age and older for whom other authorized or approved vaccines are not...

Real-World Evidence Shows Pfizer’s Ibrance Improves Breast Cancer

by Samantha McGrail

Pfizer recently presented real-world evidence demonstrating a significant benefit for patients treated with Ibrance (palbociclib) combined with an aromatase inhibitor (AI) compared to AI...

Pfizer’s COVID-19 Treatment Reduces Disease by 37% Post-Exposure

by Samantha McGrail

Pfizer recently announced that its COVID-19 treatment, Paxlovid reduced disease by 32% and 37% in adults for 5–10 days, respectively, compared to placebo.   The Phase 2/3 EPIC-PEP study...